Outlook Therapeutics, Inc.

Q3 2024 13F Holders

Symbol
OTLK
CUSIP
69012T305
Type
Equity
Class
COM
Num filings
72
Total reported value, excl. options
$42.4 M
Manager Report Date Value ($000) Shares Option Type